Imatinib Use Either Pre- Or Post-Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) Does Not Increase Cardiac Toxicity in Chronic Myelogenous Leukemia Patients
Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.441
Full Text
Open PDFAbstract
Available in full text
Date
February 9, 2009
Authors
Publisher
Springer Science and Business Media LLC